TAFA5 and depressive symptom measurement: Moreover, FAM19A5, a novel marker associated with reactive astrogliosis and neuroinflammation [83], was found to be significantly elevated in depression patients [84], indicating an inflammatory phenotype of astrocytes in depressive conditions.